Measure Exposure Of Tanezumab In Healthy Volunteers When Administering The Drug Subcutaneously

This study has been completed.

Sponsor:

Information provided by:

Pfizer

ClinicalTrials.gov Identifier:

NCT00788294

First received: November 7, 2008

Last updated: July 14, 2009

Last verified: July 2009

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	June 2009
Primary Completion Date:	June 2009 (Final data collection date for primary outcome measure)